CARY, N.C.--(BUSINESS WIRE)--JMP® Clinical 3, just released by business analytics leader SAS, offers new ways to interactively explore safety data in clinical trials, streamlining the review process ...

SAS and Ingenuity Systems have announced a partnership aimed at streamlining the discovery of important biological connections from high-throughput microarray experiments. Integration between JMP ...

JMP® Genomics 3.1, new from SAS, gives scientists important new tools in their quest to understand the causes of human disease. This all-in-one genomics software for the desktop now includes ...

Investing.com - JMP Securities has reiterated its Market Outperform rating and $90.00 price target on Crinetics (NASDAQ:CRNX) following new long-term safety and efficacy data for its lead drug ...